Updated on 14 January 2013
Sanofi, OctoPlus sign drug formulation deal
Singapore: Pharma giant, Sanofi has collaborated with OctoPlus, an advanced drug formulation and clinical scale manufacturing services provider, in formulation development.
Mr Jan Egberts, CEO of OctoPlus said, "We are proud of the confidence Sanofi has shown in our organization by signing this agreement. It reflects the success of our scientists and engineers who continuously develop new formulations and formulation processes, thereby strongly adding to the value of our clients' products."
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
